1 week ago
6
Sarah Sidlow, The Motley Fool
Thu, January 8, 2026 astatine 10:38 AM CST 6 min read
-
9,720,000 shares were sold indirectly for a transaction worth of ~$158.7 cardinal connected Dec. 3, 2025.
-
The merchantability represented 22.18% of full indirect holdings, reducing indirect vulnerability from 43,822,952 to 34,102,952 shares.
-
All shares were sold done indirect entities, with nary nonstop ownership earlier oregon aft the transaction.
-
These 10 stocks could mint the adjacent question of millionaires ›
On Dec. 3, 2025, Warburg Pincus & Co. executed an indirect merchantability of 9,720,000 shares of Sotera Health Company (NASDAQ:SHC) for a full information of $158,727,600, arsenic disclosed successful the SEC Form 4 filing.
| Shares sold (indirect) | 9,720,000 |
| Transaction value | $158.7 million |
| Post-transaction shares (direct) | |
| Post-transaction shares (indirect) | 34,102,952 |
| Post-transaction worth (direct ownership) | $0.00 |
Transaction worth based connected SEC Form 4 reported terms ($16.33).
-
How important was this merchantability successful the discourse of the insider’s remaining position?
The 9,720,000 shares sold accounted for 22.18% of Warburg Pincus & Co.'s indirect stake, marking a continued simplification and leaving 34,102,952 shares indirectly held aft the transaction. -
What channels were utilized for the disposition, and who holds the residual ownership?
The merchantability was executed wholly done indirect entities -- chiefly Bull Holdco L.P. and Bull Co-Invest L.P. -- with the insider holding nary nonstop shares earlier oregon aft the event; residual shares stay attributed to these indirect entities arsenic elaborate successful the filing’s footnotes. -
How does the transaction size comparison to humanities enactment by this insider?
Relative to a humanities median merchantability size of 12,000,000 shares successful the caller period, the 9,720,000-share artifact ranks astatine the little end, a relation of decreased disposable capableness pursuing aggregate ample anterior sales. -
Did marketplace conditions play a relation successful timing the transaction?
The transaction was executed astatine astir $16.33 per share, with Sotera Health banal priced astatine $16.84 astatine the marketplace adjacent connected the aforesaid time and up 31.25% twelvemonth implicit twelvemonth arsenic of Dec. 3, 2025, providing liquidity conditions favorable for a ample artifact sale.
| Revenue (TTM) | $1.15 billion |
| Net income (TTM) | $55.43 million |
| Dividend yield | 0.00% |
| 1-year terms change | 31.25% |
* 1-year show calculated arsenic of Dec. 3, 2025.
-
Offers sterilization services (gamma, electron beam, and EO processing), microbiological and analytical chemistry laboratory testing, and advisory services for aesculapian instrumentality and biopharmaceutical industries.
-
Generates gross chiefly done work contracts with healthcare, pharmaceutical, and nutrient manufacture clients, leveraging specialized infrastructure and regulatory expertise.
-
Main customers see aesculapian instrumentality manufacturers, pharmaceutical companies, and producers of nutrient and cultivation products globally.
.png)
English (CA) · 
English (US) · 
Spanish (MX) ·